Home > National Drug Code (NDC) > ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL - 51285-445-21 - (ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL)

Alphabetical Index


Drug Information of ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

Product NDC: 51285-445
Proprietary Name: ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Non Proprietary Name: ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Active Ingredient(s): 200; 600    mg/5mL; mg/5mL & nbsp;   ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Administration Route(s): ORAL
Dosage Form(s): GRANULE, FOR SUSPENSION
Coding System: National Drug Codes(NDC)

Labeler Information of ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

Product NDC: 51285-445
Labeler Name: Teva Women's Health, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: ANDA062759
Marketing Category: ANDA
Start Marketing Date: 19980601

Package Information of ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

Package NDC: 51285-445-21
Package Description: 150 mL in 1 BOTTLE (51285-445-21)

NDC Information of ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL

NDC Code 51285-445-21
Proprietary Name ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Package Description 150 mL in 1 BOTTLE (51285-445-21)
Product NDC 51285-445
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL
Dosage Form Name GRANULE, FOR SUSPENSION
Route Name ORAL
Start Marketing Date 19980601
Marketing Category Name ANDA
Labeler Name Teva Women's Health, Inc.
Substance Name ERYTHROMYCIN ETHYLSUCCINATE; SULFISOXAZOLE ACETYL
Strength Number 200; 600
Strength Unit mg/5mL; mg/5mL
Pharmaceutical Classes Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient],Sulfonamide Antimicrobial [EPC],Sulfonamides [Chemical/Ingredient]

Complete Information of ERYTHROMYCIN ETHYLSUCCINATE AND SULFISOXAZOLE ACETYL


General Information